Table 1 Cumulative incidence of long COVID signs and symptoms in Africa.

From: Incidence and burden of long COVID in Africa: a systematic review and meta-analysis

System

Number of cohorts

Total sample size

Cumulative incidence

95% CI

Any

25

29,213

48.6

37.4–59.8

Neurological

 Headache

14

10,515

12.7

9.8–15.5

 Taste disorder (ageusia or dysgeusia)

11

9128

7.1

5.0–9.1

 Smell disorder (anosmia)

12

9926

6.7

5.0–8.4

 Cognitive impairment

4

2448

15.0

10.2–19.7

 Memory deficits

3

2148

7.7

4.3–11.1

 Difficulty concentrating

4

5635

10.7

5.5–16.0

 Dizziness

9

8782

6.7

4.2–9.2

 Tremors

2

812

1.2

0.4–1.9

 Seizures

2

4499

0.2

0.05–0.25

 Cramps

1

538

2.6

1.6–4.3

 Visual impairment

5

6134

7.4

3.7–11.1

Psychiatric

 PTSD

2

341

25.8

21.1–30.4

 Depression

10

18,811

18.2

10.9–25.4

 Sleep disorders

13

8333

20.3

15.8–24.8

 Anxiety

8

3171

24.4

18.0–30.8

Respiratory

 Cough

9

7836

10.7

7.5–13.8

 Dyspnea

12

8057

18.3

12.2–24.4

 Nasal congestion

2

3700

1.9

1.4–2.3

 Voice change

1

115

5.2

2.4–10.9

Mobility issues

 Mobility impairment

2

3700

1.4

1.0–1.8

 Mobility decline

2

3700

0.9

0.6–1.2

Heart

 Palpitations

8

5771

11.0

7.4–14.6

Digestive

 Abdominal pain

9

7210

6.1

4.0–8.1

 Diarrhea

8

6908

6.2

4.3–8.2

 Vomit

5

2626

1.5

0.6–2.3

 Loss of appetite

6

4929

12.7

9.0–16.4

Skin

 Rash

6

6400

2.3

1.2–3.3

 Hair loss

3

3872

3.5

1.7–5.3

General

 Weight loss

4

2726

10.4

4.2–16.7

Constitutional

 Myalgia

11

7364

15.5

11.1–19.9

 Pain

11

8590

11.1

8–14.1

 Fever

7

6974

9.9

6.7–13.0

 Fatigue

15

10,577

35.4

25.6–45.2

 Arthralgia

10

7285

17.3

12.4–22.2

 Sore throat

6

1493

5.7

2.4–9.0

 Sweats

2

446

4.6

2.7–6.5

 Poor QoL

1

174

25.3

19.4–32.2

  1. Data are reported as cumulative incidence with their 95% confidence intervals.
  2. PTSD post-traumatic stress disorder, QoL quality of life.
  3. Significant values are in bold.